Sedative tolerance accompanies tolerance to the analgesic effects of fentanyl in infant rats

Pediatric Research

Volumn 47, Issue 6, 2000, Pages 727-735

  Choe, Cassandra H ^a   Smith, Forrest L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIHYDROETORPHINE; FENTANYL CITRATE; MIDAZOLAM; MORPHINE; SODIUM CHLORIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ARTIFICIAL VENTILATION; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG CROSS TOLERANCE; DRUG EFFICACY; DRUG POTENCY; EXTRACORPOREAL OXYGENATION; FEMALE; MALE; NEWBORN; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; RIGHTING REFLEX; SEDATION; TAIL FLICK TEST;

EID: 0034080183     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200006000-00008     Document Type: Article

References (45)

1. McLaughlin CR, Hull JG, Edwards WH, Cramer CP, Dewey WL 1993 Neonatal pain: a comprehensive survey of attitudes and practices. J Pain Symptom Manage 8:7-16
2. Arnold JH, Truog RD, Orav EJ, Scavone JM, Fenton, T 1991 Changes in pharmacodynamic response to fentanyl in neonates during continuous infusion. J Pediatr 119:639-643
3. Arnold JH, Truog RD, Orav EJ, Scavone JM, Hershenson MB 1990 Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 73:1136-1140
4. Franck LS, Vilardi J, Durand D, Powers R 1998 Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care 7:364-369
5. Orsini AJ, Leef KH, Costarino A, Dettorre MD, Stefano JL 1996 Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr 129:140-145
6. Roth B, Schlunder C, Houben F, Gunther M, Theisohn M 1991 Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion. Dev Pharmacol Ther 17:121-127
7. Jacqz-Aigrain E, Burtin P 1996 Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet 31:423-443
8. Bruck K, Parmelee AH, Bruck M 1962 Neutral temperature range and range of "thermal comfort" in premature infants. Biol Neonate 4:32-39
9. Tholl DA, Wager MS, Sajous CH, Myers TF 1994 Morphine use and adverse effects in a neonatal intensive care unit. Am J Hosp Pharm 51:2801-2803
10. Norton SJ 1988 After-effects of morphine and fentanyl analgesia: a retrospective study. Neonatal Netw 7:25-28
11. French JP, Nocera M 1994 Drug withdrawal symptoms in children after continuous infusion of fentanyl. J Pediatr Nurs 9:107-109
12. Katz R, Kelly HW, Hsi A 1994 Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med 22:763-767
13. Tobias JD, Deshpande JK, Gregory DF 1994 Outpatient therapy of iatrogenic drag dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Med 20:504-507
14. Franck L, Vilardi J 1995 Assessment and management of opioid withdrawal in ill neonates. Neonatal Netw 14:39-48
15. Anand KJ, Arnold JH 1994 Opioid tolerance and dependence in infants and children. Critical Care Med 22:334-342
16. Thornton SR, Smith FL 1997 Characterization of neonatal rat fentanyl tolerance and dependence. J Pharmacol Exp Ther 281:514-521
17. Thomton SR, Smith FL 1998 Long-term alterations in opioid antinociception resulting from infant fentanyl tolerance and dependence. Eur J Pharmacol 363:113-119
18. Van Praag H, Frenk H 1991 Evidence for opiate tolerance in newborn rats. Dev Brain Res 60:99-102
19. Barr GA, Wang S 1992 Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup. Eur J Pharmacol 215:35-42
20. Windh RT, Little PJ, Kuhn CM 1995 The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies. J Pharmacol Exp Ther 273:1361-1374
21. Thornton SR, Wang AK, Smith FL 1997 Characterization of neonatal rat morphine tolerance and dependence. Eur J Pharmacol 340:161-167
22. Thornton SR, Compton DR, Smith FL 1998 Ontogeny of mu opioid agonist antinociception in postnatal rats. Dev Brain Res 105:269-276
23. Harris LS, Pierson AK 1964 Some narcotic antagonists in the benzommorphan series. J Pharmacol Exp Ther 143:141-148
24. Bliss CI 1967 Statistics in Biology. McGraw-Hill, New York, p 439
25. Tallarida RJ, Murray RB 1987 Manual of Pharmacologic Calculations with Computer Programs. Springer-Verlag, New York, pp 19-22
26. Colquhoun D 1971 Lectures on Biostatistics: An Introduction to Statistics with Applications in Biology and Medicine. Clarendon Press, Oxford, UK, pp 327-332
27. De Lean A, Munson PJ, Rodbard D 1978 Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102
28. Wallace H, Pate A, Bishop JO 1995 Effects of perinatal thyroid hormone deprivation on the growth and behaviour of newborn mice. J Endocrinol 145:251-262
29. Montella P, Reddy C 1991 Neurotoxic effects of secalonic acid D in mice during subchronic postnatal exposure. Pharmacol Biochem Behav 40:241-247
30. Kurishingal H, Palanza P, Brain P 1992 Effects of exposure of pregnant mice to chlordiazepoxide (CDP) on the development and ultrasound production of their offspring. Gen Pharmacol 23:49-53
31. Litchfield JT, Wilcoxon F 1949 A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
32. Koehntop DE, Rodman JH, Brundage DM, Hegland MG, Buckley JJ 1986 Pharmacokinetics of fentanyl in neonates. Anesth Analg 65:227-232
33. Gauntlett IS, Fisher DM, Hertzka RA, Kuhls E, Spellman MJ, Rudolph C 1988 Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 69:683-687
34. Spain JW, Roth BL, Coscia CJ 1985 Differential ontogeny of multiple opioid receptors (mu, delta and kappa). J Neurol 5:584-588
35. Jackson H, Kitchen I 1989 Behavioural effects of selective μ-, κ-, and δ-opioid aganosts in neonatal rats. Psychopharmacology (Berl) 97:404-409
36. Levene M 1995 Pain relief and sedation during neonatal intensive care. Eur J Pediatr 154:S22-S23
37. Paronis CA, Holtzman SG 1992 Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J Pharmacol Exp Ther 262:1-9
38. Huang M, Qin BY 1982 Analgesic and other CNS depressive effects of dihydroetorphine. Acta Pharmacol Sin 3:9-13
39. Wang D, Lu X, Qin B 1995 Dihydroetorphine is a μ-receptor-selective ligand. J Pharm Pharmacol 47:669-673
40. Wang DX, Liu YS, Qin BY 1992 Experimental therapeutic effects of dihydroetorphine in morphine dependent rats and monkeys. Clin J Pharmacol Toxicol 6:36-40
41. Qin BY 1993 Research advances of dihydroetorphine: from analgesia to detoxification. New Drugs Clin Remedies 12:119-126
42. Kamei J, Suzuki T, Nagase H 1996 Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice. Neurosci Lett 215:87-90
43. Tallarida RJ, Jacob LS 1979 The Dose-Response Relation in Pharmacology. Springer-Verlag, New York, pp 67-72
44. Hug CC, Murphy MR 1981 Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology 55:369-375
45. Ghosal A, Satoh H, Thomas PE, Bush E, Moore D 1996 Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450. Drug Metab Dispos 24:940-947